Laboratorio Reig Jofre, S.A. (BME:RJF)

Market Cap	226.57M
Revenue (ttm)	338.90M
Net Income (ttm)	10.47M
Shares Out	80.06M
EPS (ttm)	n/a
PE Ratio	21.65
Forward PE	15.72
Dividend	0.04 (1.40%)
Ex-Dividend Date	May 17, 2024

Volume	39,883
Average Volume	38,550
Open	2.830
Previous Close	2.830
Day's Range	2.790 - 2.970
52-Week Range	2.440 - 3.380
Beta	0.90
RSI	60.83
Earnings Date	May 9, 2025

About Laboratorio Reig Jofre

Laboratorio Reig Jofre, S.A., a pharmaceutical company, engages in the research, development, manufacture, and marketing of pharmaceutical products and specialties, as well as accessories authorized foodstuffs, dietary and personal care products, and cosmetics. The company offers nutritional and parapharmacy products. Its products also include pharmaceutical technologies products, such as antibiotics, and injectables and other products; specialty pharmacare products, which include skin, hair, nails, joint health and pain, and women’s health; an...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1929
• Employees: 1,331
• Stock Exchange: Madrid Stock Exchange
• Ticker Symbol: RJF

Financial Performance

In 2024, Laboratorio Reig Jofre's revenue was 338.90 million, an increase of 6.59% compared to the previous year's 317.95 million. Earnings were 10.47 million, an increase of 11.27%.